Expression profile of SARS-CoV-2 cellular entry proteins in normal oral mucosa and oral squamous cell carcinoma

Dipak Sapkota1, Sunita Sharma1, Tine M Søland1,2

  • 1Department of Oral Biology, Faculty of Dentistry, University of Oslo, Oslo, Norway.

Abstract

Insights

Normal oral mucosa shows lower expression of SARS-CoV-2 entry proteins compared to oral cancer lesions. This suggests normal oral tissue may be less susceptible to viral attachment, with no increased risk for oral squamous cell carcinoma.

Area of Science:

  • Virology
  • Oncology
  • Molecular Biology

Background:

  • Cellular entry of SARS-CoV-2 relies on angiotensin converting enzyme 2 (ACE2) and proteases like FURIN and TMPRSS2.
  • Simultaneous profiling of these entry proteins can enhance risk assessment for SARS-CoV-2 infection.
  • Oral squamous cell carcinoma (OSCC) and normal oral mucosa (NOM) susceptibility to SARS-CoV-2 requires investigation.

Purpose of the Study:

  • To compare the expression profiles of SARS-CoV-2 entry proteins (ACE2, FURIN, TMPRSS2) in OSCC versus NOM.
  • To assess the relative susceptibility of OSCC lesions and NOM to SARS-CoV-2 attachment and entry.

Main Methods:

  • Utilized public transcriptomic and proteomics datasets, including TCGA, GTEx, and HPA.
  • Examined mRNA and protein expression levels of ACE2, FURIN, and TMPRSS2 in NOM and OSCC tissues.

Main Results:

  • ACE2, TMPRSS2, and FURIN mRNAs were detected in NOM, but at lower levels than in other body tissues.
  • OSCC tissues showed unchanged or down-regulated ACE2 and TMPRSS2 mRNA expression compared to NOM.
  • FURIN mRNA expression was moderately up-regulated in OSCC relative to NOM.

Conclusions:

  • NOM may be a potential site for SARS-CoV-2 attachment, albeit less so than organs with higher entry protein expression.
  • Current evidence does not support that the expression status of these entry proteins increases the risk for OSCC lesions regarding SARS-CoV-2 attachment/entry compared to NOM.